Nova Cannabis Stock Price To Book
| NVACFDelisted Stock | USD 1.26 0.00 0.00% |
Nova Cannabis fundamentals help investors to digest information that contributes to Nova Cannabis' financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Cannabis otc stock.
Nova |
Nova Cannabis OTC Stock Price To Book Analysis
Nova Cannabis' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Nova Cannabis Price To Book | 0.44 X |
Most of Nova Cannabis' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Nova Cannabis has a Price To Book of 0.4354 times. This is 98.3% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The price to book for all United States stocks is 95.42% higher than that of the company.
Nova Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Cannabis' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Cannabis could also be used in its relative valuation, which is a method of valuing Nova Cannabis by comparing valuation metrics of similar companies.Nova Cannabis is currently under evaluation in price to book category among its peers.
Nova Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0287 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 59.13 M | |||
| Shares Outstanding | 57.15 M | |||
| Shares Owned By Insiders | 62.72 % | |||
| Shares Owned By Institutions | 5.20 % | |||
| Price To Book | 0.44 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 134.36 M | |||
| Gross Profit | 24.89 M | |||
| EBITDA | (7.32 M) | |||
| Net Income | (20.61 M) | |||
| Cash And Equivalents | 6.22 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 60.11 M | |||
| Debt To Equity | 1.11 % | |||
| Current Ratio | 1.07 X | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (9.98 M) | |||
| Earnings Per Share | (0.30) X | |||
| Number Of Employees | 548 | |||
| Market Capitalization | 35.92 M | |||
| Total Asset | 118.7 M | |||
| Z Score | 1.0 | |||
| Net Asset | 118.7 M |
About Nova Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Nova Cannabis information on this page should be used as a complementary analysis to other Nova Cannabis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Nova OTC Stock
If you are still planning to invest in Nova Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nova Cannabis' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |